Patent office ruling in favor of Neuralstem leads to stay of Stemcells Inc. lawsuit

Download PDF Copy

Editorial Checklist

Reviewed

Jun 27 2007

NewsGuard 100/100 Score

Neuralstem Inc. has announced that StemCells Inc. has consented to a stay of the lawsuit it filed against Neuralstem in August 2006.

The motion also stays Neuralstem's Counter Claims against StemCells Inc. indefinitely.

The U.S. Patent Office recently ruled in favor of Neuralstem and ordered re-examinations of all the StemCells Inc. patents in a suit finding that there were "serious new questions of patentability" problems with each claim of every patent under re- examination.

Neuralstem has its own issued patents relating to its human neural stem cell technology. These patents are not being challenged in the litigation between the companies.

"We have alleged in the litigation that the patents StemCells. Inc. was seeking to assert against us were invalid, and we are certainly not surprised that the Patent Office has now ruled that there are serious new questions of patentability with their claims," said Neuralstem CEO, Richard Garr.

Source:

http://www.neuralstem.com/

Posted in: Medical Patent News

Tags: B Cell, Cell, Medical Litigation, Neural Stem Cells, Stem Cells, T-Cell, Technology

Comments (0)

Download PDF Copy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.